Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS). (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.42772
PubMed Identifier: 38073013
Publication URI: http://europepmc.org/abstract/MED/38073013
Type: Journal Article/Review
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5191